has part has core process phospholipidosis (latent) PMID:15342952 PMID:16979167 PMID:22960355 The totality of all processes through which the phospholipidosis is realized. This entity represents latent phospholipidosis, which describes the course of processes before toxic manifestation. In the drug exposure situation in phospholipidosis, it is known that CADs affect biological functioning. CADs bind to lysosomal membranes and form a complex with phospholipids, which negatively regulates phospholipid degradation. Therefore, the defence system cannot perform a ‘high’ level, i.e. there is a lack of adaptation. Under normal conditions, although the cell system can maintain the balance between increasing and decreasing phospholipid at a ‘medium’ level, in this state, the cellular system is in what is called the latent stage. maintaining phospholipid homeostasis [Phospholipidosis (latent)] phospholipid metabolism balance [Phospholipidosis (latent) ] CAD accumulation in lysosome [Phospholipidosis (latent)] phospholipidosis (course) compound accumulation in lysosome [Phospholipidosis (latent)] negative regulation of phospholipid degradation [Phospholipidosis (latent)] hypofunction of phospholipid degradation [Phospholipidosis(latent)] phospholipid biosynthetic process [Phospholipidosis(latent)]